FindTrial
Sign In

A Retrospective Study to Evaluate the Predictability of Abnormal Arterial Blood Gas Measurements Through Novel Observations of Continuous Trends in Electronically Measured Respiratory Rate in a Mixed Cohort of Respiratory Compromised Patients

A Retrospective Study to Evaluate the Predictability of Abnormal Arterial Blood Gas Measurements Through Novel Observations of Continuous Trends in Electronically Measured Respiratory Rate in a Mixed Cohort of Respiratory Compromised Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05384314
Enrollment
322
Registered
2022-05-20
Start date
2021-07-12
Completion date
2022-12-12
Last updated
2022-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community-acquired Pneumonia, COPD, COVID-19, Pneumonia, Pulmonary Disease, Respiratory Failure

Keywords

Respiratory Rate, Arterial Blood Gas

Brief summary

A retrospective study to evaluate the predictability of abnormal arterial blood gas measurements through novel observations of continuous trends in electronically measured respiratory in a mixed cohort of respiratory compromised patients.

Interventions

DEVICERespiraSense

The use of continuous electronic monitoring of respiratory rate

Sponsors

Beaumont Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Respiratory condition is the primary admission diagnosis

Exclusion criteria

* Pregnant patients in their 2nd or 3rd trimester

Design outcomes

Primary

MeasureTime frameDescription
Positive Predictive Value/Precision (PPV)12 monthsPositive Predictive Value/Precision (PPV) of an elevated RespiraSense monitoring Respiratory Rate (RR) for an abnormal ABG - for a single disease state (COPD)

Secondary

MeasureTime frameDescription
PPV of an elevated RR for an abnormal ABG - for a mix of disease states12 monthsPPV of an elevated RR for an abnormal ABG - for a mix of disease states, all of which fall under Respiratory Failure

Other

MeasureTime frameDescription
PPV of elevated RR6 monthsPPV of elevated RR (for each of i. and ii. above) for requirement of a meaningful intervention

Countries

Ireland

Contacts

Primary ContactRichard Costello
rcostello@rcsi.ie+353(0)18093000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026